Organovo Holdings Stock Analysis

Organovo Stock Analysis Notes

About 16.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.54. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Organovo Holdings recorded a loss per share of 1.04. The entity last dividend was issued on the 19th of August 2020. The firm had 1:20 split on the 19th of August 2020. Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. The company was incorporated in 2007 and is headquartered in Solana Beach, California. Organovo Holdings operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. To find out more about Organovo Holdings contact Keith Murphy at 858 224 1000 or learn more at https://www.organovo.com.

Organovo Holdings Investment Alerts

Organovo Holdings Upcoming and Recent Events

Organovo Largest EPS Surprises

View All Earnings Estimates

Organovo Stock Institutional Investors

Note, although Organovo Holdings' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Organovo Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.67 M.

Organovo Profitablity

Management Efficiency

Organovo Holdings has return on total asset (ROA) of (0.891) % which means that it has lost $0.891 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.0669) %, meaning that it created substantial loss on money invested by shareholders. Organovo Holdings' management efficiency ratios could be used to measure how well Organovo Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Organovo Holdings' Return On Capital Employed is very stable compared to the past year. As of the 18th of December 2024, Return On Equity is likely to grow to 8.21, while Return On Tangible Assets are likely to drop (2.62). At this time, Organovo Holdings' Other Current Assets are very stable compared to the past year. As of the 18th of December 2024, Non Current Assets Total is likely to grow to about 2.4 M, while Total Assets are likely to drop about 6 M.

Technical Drivers

As of the 18th of December 2024, Organovo Holdings holds the Risk Adjusted Performance of (0.04), coefficient of variation of (1,422), and Variance of 28.53. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organovo Holdings, as well as the relationship between them.

Organovo Holdings Price Movement Analysis

Organovo Holdings Insider Trading Activities

Organovo Holdings Outstanding Bonds

Organovo Holdings Predictive Daily Indicators

Organovo Holdings Forecast Models

Organovo Holdings' time-series forecasting models are one of many Organovo Holdings' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Organovo Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Organovo Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Organovo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Organovo Holdings. By using and applying Organovo Stock analysis, traders can create a robust methodology for identifying Organovo entry and exit points for their positions.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.